AST-301

pNGVL3-hICD · Aston Sci. Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AST-301, covering 2024-06-17 to 2024-07-10. Get the full timeline:

Most recent: Clinical Trial Update: Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Gastric Cancer [Phase 2]